Of the three currently used drugs that have been shown to specifically inhibit TB (Table 3), INH and ETA both target inhA and EMB targets embC, A, and B. Only EMB targets could be prioritized as being M. tuberculosis-specific (Table 3): embC and B rank higher than our 13% criterion, and embA ranks 628. This evidence concerns the gene INHA and tuberculosis.